337 related articles for article (PubMed ID: 26311253)
1. Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
Lok E; Hua V; Wong ET
Cancer Med; 2015 Nov; 4(11):1697-9. PubMed ID: 26311253
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.
Korshoej AR; Hansen FL; Thielscher A; von Oettingen GB; Sørensen JCH
PLoS One; 2017; 12(6):e0179214. PubMed ID: 28604803
[TBL] [Abstract][Full Text] [Related]
3. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
Riley MM; San P; Lok E; Swanson KD; Wong ET
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901
[TBL] [Abstract][Full Text] [Related]
5. Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma.
Lok E; San P; Hua V; Phung M; Wong ET
Cancer Med; 2017 Jun; 6(6):1286-1300. PubMed ID: 28544575
[TBL] [Abstract][Full Text] [Related]
6. The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study.
Wenger C; Salvador R; Basser PJ; Miranda PC
Phys Med Biol; 2015 Sep; 60(18):7339-57. PubMed ID: 26350296
[TBL] [Abstract][Full Text] [Related]
7. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
Guberina N; Pöttgen C; Kebir S; Lazaridis L; Scharmberg C; Lübcke W; Niessen M; Guberina M; Scheffler B; Jendrossek V; Jabbarli R; Pierscianek D; Sure U; Schmidt T; Oster C; Hau P; Grosu AL; Stuschke M; Glas M; Nour Y; Lüdemann L
Radiat Oncol; 2020 Apr; 15(1):83. PubMed ID: 32307022
[TBL] [Abstract][Full Text] [Related]
8. Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts.
Wenger C; Salvador R; Basser PJ; Miranda PC
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1137-43. PubMed ID: 26883559
[TBL] [Abstract][Full Text] [Related]
9. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
[TBL] [Abstract][Full Text] [Related]
10. Simplified realistic human head model for simulating Tumor Treating Fields (TTFields).
Wenger C; Bomzon Z; Salvador R; Basser PJ; Miranda PC
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():5664-5667. PubMed ID: 28269540
[TBL] [Abstract][Full Text] [Related]
11. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
12. A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.
Trusheim J; Dunbar E; Battiste J; Iwamoto F; Mohile N; Damek D; Bota DA; Connelly J
CNS Oncol; 2017 Jan; 6(1):29-43. PubMed ID: 27628854
[TBL] [Abstract][Full Text] [Related]
13. First steps to creating a platform for high throughput simulation of TTFields.
Hershkovich HS; Bomzon Z; Wenger C; Urman N; Chaudhry A; Garcia-Carracedo D; Kirson ED; Weinberg U; Wassermann Y; Palti Y
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2357-2360. PubMed ID: 28268799
[TBL] [Abstract][Full Text] [Related]
14. Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
[TBL] [Abstract][Full Text] [Related]
15. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
Jo Y; Kim EH; Sai S; Kim JS; Cho JM; Kim H; Baek JH; Kim JY; Hwang SG; Yoon M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469352
[TBL] [Abstract][Full Text] [Related]
16. Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study.
Sun YS
Comput Math Methods Med; 2018; 2018():3829768. PubMed ID: 29681995
[TBL] [Abstract][Full Text] [Related]
17. Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.
Connelly J; Hormigo A; Mohilie N; Hu J; Chaudhry A; Blondin N
BMC Cancer; 2016 Nov; 16(1):842. PubMed ID: 27809808
[TBL] [Abstract][Full Text] [Related]
18. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.
Lok E; Swanson KD; Wong ET
Expert Rev Med Devices; 2015; 12(6):717-26. PubMed ID: 26513694
[TBL] [Abstract][Full Text] [Related]
19. Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors.
Benson L
Semin Oncol Nurs; 2018 May; 34(2):137-150. PubMed ID: 29631935
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study.
Korshoej AR; Saturnino GB; Rasmussen LK; von Oettingen G; Sørensen JC; Thielscher A
PLoS One; 2016; 11(10):e0164051. PubMed ID: 27695068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
